STOCK TITAN

AMRZ Stock Price, News & Analysis

AMRZ NYSE

Welcome to our dedicated page for AMRZ news (Ticker: AMRZ), a resource for investors and traders seeking the latest updates and insights on AMRZ stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect AMRZ's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of AMRZ's position in the market.

Rhea-AI Summary
Amrize (NYSE: AMRZ) has successfully completed its 100% spin-off from Holcim, debuting as an independent, publicly traded company on the NYSE and SIX Swiss Exchange. The company, with 19,000 employees and over 1,000 sites across North America, serves professional builders with comprehensive construction solutions. In 2024, Amrize generated impressive financial results with $11.7B in revenue (13% CAGR from 2021), $3.2B in Adjusted EBITDA (16% CAGR), and $1.7B in Free Cash Flow (15% CAGR). The company maintains a strong 27% Adjusted EBITDA margin and has completed 36 acquisitions since 2018. As an independent entity, Amrize plans to focus on growth through business investments, M&A activities, and delivering superior shareholder returns.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
AMRZ

NYSE:AMRZ

AMRZ Rankings

AMRZ Stock Data